User profiles for Karen E. Doucette

Karen Doucette

University of Alberta
Verified email at ualberta.ca
Cited by 3899

Management of hepatitis B virus infection: 2018 guidelines from the Canadian Association for the Study of Liver Disease and Association of Medical Microbiology and …

…, KE Doucette, C Fournier, E Kelly… - Canadian Liver …, 2018 - canlivj.utpjournals.press
Hepatitis B virus (HBV) infection is an important public health problem in Canada. In keeping
with evolving evidence and understanding of HBV pathogenesis, the Canadian Association …

Efficacy and safety of antimicrobial stewardship prospective audit and feedback in patients hospitalised with COVID-19 (COVASP): a pragmatic, cluster-randomised …

…, M Yaskina, D Kabbani, KE Doucette… - The Lancet Infectious …, 2023 - thelancet.com
Background The COVID-19 pandemic has been associated with increased antimicrobial use
despite low rates of bacterial co-infection. Prospective audit and feedback is recommended …

Oseltamivir: a clinical and pharmacological perspective

FY Aoki, KE Doucette - Expert Opinion on Pharmacotherapy, 2001 - Taylor & Francis
Oseltamivir is the ethyl ester prodrug of the antiviral molecule, oseltamivir carboxylate, a
potent and selective inhibitor of influenza A and B neuraminidase (NA) (sialidase). It is highly …

[HTML][HTML] Molecular epidemiology and clinical characteristics of hepatitis D virus infection in Canada

…, D Wong, GY Minuk, KE Doucette, P Wong, E Tam… - JHEP Reports, 2022 - Elsevier
Background & Aims HDV affects 4.5–13% of chronic hepatitis B (CHB) patients globally, yet
the prevalence of HDV infection in Canada is unknown. To investigate the prevalence, …

Prospective monitoring of BK polyomavirus infection early posttransplantation in nonrenal solid organ transplant recipients

KE Doucette, XL Pang, K Jackson, I Burton… - …, 2008 - journals.lww.com
Background. BK virus-associated nephropathy is an important cause of renal dysfunction in
renal transplant recipients. Renal dysfunction after nonrenal solid organ transplantation (…

Epidemiologic and clinical features of chronic hepatitis B virus infection in 8 Canadian provinces: a descriptive study by the Canadian HBV Network

…, D Miles, KE Doucette, P Wong, E Tam… - … Open Access Journal, 2019 - cmajopen.ca
Background: Published Canadian epidemiologic data on hepatitis B virus (HBV) infection
include single-centre studies or are focused on Indigenous populations. We performed a study …

Posttransplant lymphoproliferative disease after allogeneic transplantation of the spleen in miniature swine

FJMF Dor, KE Doucette, NJ Mueller… - …, 2004 - journals.lww.com
Spleen transplantation (SpTx) was performed in miniature swine across full major histocompatibility
complex barriers to study the tolerogenic effect of the spleen. This study describes …

[HTML][HTML] Efficacy and safety of antimicrobial stewardship prospective audit and feedback in patients hospitalized with COVID-19: A protocol for a pragmatic clinical trial

…, HL Hoang, M Yaskina, D Kabbani, KE Doucette… - PloS one, 2022 - journals.plos.org
Background The use of broad-spectrum antibiotics is widespread in patients with COVID-19
despite a low prevalence of bacterial co-infection, raising concerns for the accelerated …

Treatment of hepatitis C in potential lung transplant candidates

KE Doucette, J Weinkauf, S Sumner, K Ens… - Transplantation, 2007 - journals.lww.com
International guidelines list hepatitis C virus (HCV) as a contraindication to lung transplant (LTx).
Since the development of these guidelines, the natural history of HCV after nonhepatic …

[HTML][HTML] Outcomes and management of viral hepatitis and human immunodeficiency virus co-infection in liver transplantation

SE Congly, KE Doucette, CS Coffin - World Journal of …, 2014 - ncbi.nlm.nih.gov
Liver transplantation for human immunodeficiency virus (HIV) positive patients with viral
hepatitis co-infection is increasingly offered in many North American and European liver …